LIAISON Helicobacter Antigen
Device
DiaSorin Inc.
Total Payments
$90,887
Transactions
13
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $1,516 | 2 | 0 |
| 2018 | $5,265 | 1 | 0 |
| 2017 | $84,106 | 10 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $90,887 | 13 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| LIAISON Helicobacter Antigen | DiaSorin Inc. | $89,371 | 0 |
| LIAISON Helicobacter Antigen Project | DiaSorin Inc. | $1,516 | 0 |
Top Doctors Receiving Payments for LIAISON Helicobacter Antigen
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | St. Louis, MO | $90,887 | 13 |
Ad
Manufacturing Companies
- DiaSorin Inc. $90,887
Product Information
- Type Device
- Total Payments $90,887
- Total Doctors 0
- Transactions 13
About LIAISON Helicobacter Antigen
LIAISON Helicobacter Antigen is a device associated with $90,887 in payments to 0 healthcare providers, recorded across 13 transactions in the CMS Open Payments database. The primary manufacturer is DiaSorin Inc..
Payment data is available from 2017 to 2019. In 2019, $1,516 was paid across 2 transactions to 0 doctors.
The most common payment nature for LIAISON Helicobacter Antigen is "Unspecified" ($90,887, 100.0% of total).
LIAISON Helicobacter Antigen is associated with 2 research studies, including "LIAISON Helicobacter Antigen" ($89,371).